ES2150305T3 - Composicion anhidra a base de lactulosa. - Google Patents

Composicion anhidra a base de lactulosa.

Info

Publication number
ES2150305T3
ES2150305T3 ES98402480T ES98402480T ES2150305T3 ES 2150305 T3 ES2150305 T3 ES 2150305T3 ES 98402480 T ES98402480 T ES 98402480T ES 98402480 T ES98402480 T ES 98402480T ES 2150305 T3 ES2150305 T3 ES 2150305T3
Authority
ES
Spain
Prior art keywords
anhydrous
lactulose
composition
anhydra
laxative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98402480T
Other languages
English (en)
Inventor
Odette Salsarulo
Gerard Salsarulo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2150305T3 publication Critical patent/ES2150305T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN MEDICAMENTO CON BASE DE LACTULOSA CARACTERIZADO POR LA INCORPORACION DE LACTULOSA ANHIDRA EN UN VEHICULO DE REVESTIMIENTO TAMBIEN ANHIDRO, QUE CONSISTE EN UNA MEZCLA DE HIDROCARBUROS PURIFICADOS FARMACEUTICAMENTE ACEPTABLES, PRESENTANDO ESTE VEHICULO UN PUNTO DE FUSION DEL ORDEN DE 37°C +/4°C. ESTA EN PARTICULAR DOSIFICADO PARA PERMITIR LA ADMINISTRACION DE 3 A 5 G POR DIA PARA UN ADULTO, EN PARTICULAR EN UNA SOLA TOMA.
ES98402480T 1997-10-21 1998-10-06 Composicion anhidra a base de lactulosa. Expired - Lifetime ES2150305T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9713186A FR2769839B1 (fr) 1997-10-21 1997-10-21 Composition anhydre a base de lactulose

Publications (1)

Publication Number Publication Date
ES2150305T3 true ES2150305T3 (es) 2000-11-16

Family

ID=9512480

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98402480T Expired - Lifetime ES2150305T3 (es) 1997-10-21 1998-10-06 Composicion anhidra a base de lactulosa.

Country Status (11)

Country Link
US (1) US6221853B1 (es)
EP (1) EP0911038B1 (es)
JP (1) JP3459349B2 (es)
AT (1) ATE194498T1 (es)
DE (1) DE69800210T2 (es)
DK (1) DK0911038T3 (es)
ES (1) ES2150305T3 (es)
FR (1) FR2769839B1 (es)
GR (1) GR3034549T3 (es)
HK (1) HK1020527A1 (es)
PT (1) PT911038E (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
RU2284832C2 (ru) * 2004-08-30 2006-10-10 Николай Александрович Киселев Антимикробная композиция для перорального введения
US7541144B2 (en) * 2005-01-31 2009-06-02 Agilent Technologies, Inc. RNA labeling method
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
LT3551164T (lt) 2016-12-08 2021-05-10 Salsarulo Pharma Geriamasis vaistas, apimantis osmosinę vidurius laisvinančią priemonę, įterptą į augalinių riebalų pagrindo matricą

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB543309A (en) * 1940-12-04 1942-02-19 John David Evans Improvements in or relating to drugs
FR2668706B1 (fr) * 1990-11-02 1995-01-20 Odette Salsarulo Composition anydre a base de lactulose.
FR2716624B1 (fr) * 1994-02-25 1996-05-03 Jouveinal Lab Gelée laxative hypocalorique à base d'huile de paraffine liquide et de lactulose, son procédé de préparation.

Also Published As

Publication number Publication date
PT911038E (pt) 2000-12-29
JPH11189538A (ja) 1999-07-13
FR2769839B1 (fr) 1999-12-17
HK1020527A1 (en) 2000-05-12
JP3459349B2 (ja) 2003-10-20
DE69800210T2 (de) 2001-03-15
ATE194498T1 (de) 2000-07-15
EP0911038B1 (fr) 2000-07-12
EP0911038A1 (fr) 1999-04-28
GR3034549T3 (en) 2001-01-31
FR2769839A1 (fr) 1999-04-23
US6221853B1 (en) 2001-04-24
DE69800210D1 (de) 2000-08-17
DK0911038T3 (da) 2000-11-27

Similar Documents

Publication Publication Date Title
DE69940769D1 (de) Orale flüssige zusammensetzungen
GB2326093A (en) Avermectin formulation
ATE353009T1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
BG105564A (en) Galantamine-containing composition with controlled release
SE8804629D0 (sv) New therapeutically active compounds
ATE390414T1 (de) Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
SE0102055D0 (sv) New Compounds
IL148874A0 (en) Sulfonyl amino acid derivatives, their preparation and pharmaceutical compositions containing them
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
ES2150305T3 (es) Composicion anhidra a base de lactulosa.
JPS5781409A (en) External plaster
YU81101A (sh) Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija
ES2064104T3 (es) Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral.
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
CO4340677A1 (es) Formulaciones novedosas conteniendo paroxetina
MY133368A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 911038

Country of ref document: ES